Rite Aid announced it is collaborating with Quest Diagnostics to provide access to quality, COVID-19 molecular testing (polymerase chain reaction or similar nucleic acid amplification test)to help Rite Aid customers detect and prevent the spread of COVID-19. Quest is the world's leading provider of diagnostic information services and a national leader in COVID-19 testing. The company has performed more than 69 million COVID-19 molecular tests since March 2020.

Through the collaboration, Rite Aid and Bartell Drugs' more than 2,350 stores, now offer access to Quest PCR testing, either through their drive-thru locations or the addition of at home specimen testing kits from stores without drive-thrus, doubling the access to PCR testing for adults and children over 2 years old. Both options require an appointment be made through the Quest website. Quest Diagnostics will provide results electronically to individuals through the MyQuest online portal and app.

Customers can schedule to pick up a COVID-19 PCR testing kit with at-home specimen collection or schedule observed drive-thru collection at https://www.riteaid.com/pharmacy/services/covid-19-testing where they will be directed to request a test through Quest's consumer-initiated test platform QuestDirect. Quest's kits come with a prepaid FedEx envelope for overnight shipping to a Quest laboratory. Currently, the average time for Quest Diagnostics to provide a test result is one to two days.

Result turnaround times can fluctuate with demand levels and vary by region and other factors.